Takahashi Shigeru, Matsuura Naomi, Kurokawa Takako, Takahashi Yuji, Miura Takashi
Laboratory of Environmental Molecular Physiology, School of Life Science, Tokyo University of Pharmacy and Life Science, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Biochem J. 2002 Nov 1;367(Pt 3):641-52. doi: 10.1042/BJ20020819.
We reported previously that the 5'-flanking region (nucleotides -1976 to -1655) of the human haem oxygenase-1 ( hHO-1 ) gene enhances hHO-1 promoter activity in human hepatoma HepG2 cells, but not in HeLa cells [Takahashi, Takahashi, Ito, Nagano, Shibahara and Miura (1999) Biochim. Biophys. Acta 1447, 231-235]. To define more precisely the regulatory elements involved, in the present study we have functionally dissected this region and localized the enhancer to a 50 bp fragment (-1793 to -1744). Site-direct mutagenesis analysis revealed that two regions were responsible for this enhancer activity, i.e. a hepatocyte nuclear factor-4 (HNF-4) homologous region and a GC box motif homologous region. Mutation in either region alone moderately decreased enhancer activity. However, mutations in both regions reduced promoter activity to the basal level. Electrophoretic mobility-shift assays demonstrated that the P5-2 fragment (-1793 to -1744) interacted with at least two nuclear factors, i.e. HNF-4 and Sp1/Sp3. Co-transfection experiments using Drosophila SL2 cells revealed that HNF-4 and Sp1/Sp3 synergistically stimulated the enhancer activity of the P5-2 fragment. These results indicate that co-operation of HNF-4 with Sp1 or Sp3 leads to the activation of hHO-1 gene expression in hepatoma cells.
我们先前报道过,人血红素加氧酶-1(hHO-1)基因的5'侧翼区(核苷酸-1976至-1655)可增强人肝癌HepG2细胞中的hHO-1启动子活性,但在HeLa细胞中则不然[高桥、高桥、伊藤、长野、柴原和三浦(1999年)《生物化学与生物物理学学报》1447,231 - 235]。为了更精确地确定所涉及的调控元件,在本研究中我们对该区域进行了功能剖析,并将增强子定位到一个50 bp的片段(-1793至-1744)。位点定向诱变分析表明,有两个区域负责这种增强子活性,即一个肝细胞核因子-4(HNF-4)同源区域和一个GC盒基序同源区域。单独在任一区域发生突变都会适度降低增强子活性。然而,两个区域都发生突变则将启动子活性降低到基础水平。电泳迁移率变动分析表明,P5 - 2片段(-1793至-1744)与至少两种核因子相互作用,即HNF-4和Sp1/Sp3。使用果蝇SL2细胞进行的共转染实验表明,HNF-4和Sp1/Sp3协同刺激P5 - 2片段的增强子活性。这些结果表明,HNF-4与Sp1或Sp3的合作导致肝癌细胞中hHO-1基因表达的激活。